Region
Mahindra Lifespace, Standard Chartered form real estate JV
Mahindra Lifespace Developers (MLD), an Indian real estate and infrastructure developer, and SCM Real Estate (SCM), a Singapore-based investment arm of Standard Chartered bank, have formed a joint venture to develop residential projects in India. The...
CIC returns to profit in 2012 on back of equities boost
China Investment Corp. (CIC) has returned to profit, reporting an annual return of 10.6% on its overseas investments last year thanks to a rally in global equities. The sovereign wealth fund saw a cumulative annualized return of 5.02% for 2012, up from...
China's Baifendian secures $10m Series B round
Baifendian, a Chinese recommendation engine that tracks user tastes and predicts how they might rate items, has received $10 million in Series B financing from Zhejiang Shinkansen Media Investment via its Eastern Starry Sky Culture Fund.
Zennon, New World invest $25m in China games developer CMGE
Zennon Capital Partners and New World Strategic Investment (NWSI) have invested $25 million in NASDAQ-listed China Mobile Games and Entertainment Group (CMGE).
CLSA Capital backs India's Luminous Water Technologies
CLSA Capital Partners (CLSACP) has invested INR 550 million ($9.2 million) in water-purifier maker Luminous Water Technologies (LWT) from its ARIA Investment Partners IV fund.
Nissay Capital backs Japanese online ad platform Dennoo
Nissay Capital has invested $1.1 million in Japanese online ad platform, Dennoo. The investment brings the start-up's total amount of venture capital funding to $3.1 million.
Japan's Meiji Yasuda beats PE to Thai Life stake
Japan’s Meiji Yasuda Life Insurance has agreed to buy a 15% stake in Thai Life Insurance for an undisclosed sum, thought to be in the region of $750 million. Other participants in the auction reportedly included the Carlyle Group, KKR and CVC Capital...
Asia Pacific Capital completes $25m Series C round for Ciris Energy
Hong Kong-based Asia Pacific Capital (APC) has invested $15 million in Ciris Energy, a US company that converts coal to natural gas, concluding a $25 million Series C round of investment.
Kroll boosts China investigations practice
Kroll Advisory Solutions has hired Peter Glanville as an associate managing director in its Greater China investigations and disputes practice. He joins from Deloitte where he was a senior member of the forensic accounting team.
DCM targets $250m for China VC fund
DCM is seeking $250 million for its latest China-focused fund. The target for Venture China Fund VII is less than the $400 million raised for DCM's previous vehicle, which invests in China, the US and Japan.
Multiples buys ICICI Venture's stake in Vikram Hospital
Multiples Alternate Asset Management has bought a 64% stake in Bangalore-based Vikram Hospital from ICICI Venture Funds Management, and also infused direct capital for debt repayment.
Femto invests $1m in Japanese restaurant app startup
Japanese venture capital firm Femto has committed JPY100 million ($1 million) of seed funding in Toreta, a start-up developing apps for the food service industry.
Revolution Growth invests $40m in Australia's Bigcommerce
US venture capital firm Revolution Growth has invested $40 million in Australian tech start-up Bigcommerce. The company sells e-commerce software for online retailers covering website design, store management, marketing and electronic payments.
Creador set for $105m first close on Fund II
India and Southeast Asia-focused GP Creador is expected to reach a first close of $105 million on its second fund by mid to late August. The full target is $250 million.
Singapore's GIC announces name change
Singapore sovereign wealth fund Government of Singapore Investment Corporation Private Limited has changed its legal name to GIC Private Limited.
Standard Chartered boosts stake as India's Fortis moves to cut debt
Standard Chartered Private Equity (SCPE) will invest a further $13.5 million in hospital chain Fortis Healthcare through a preferential allotment of shares, taking its total holding to around 2.7%.
EQT mulls deal for Dairy Queen, Papa John's China franchisee – report
EQT Partners intends to buy a minority stake in RCS Group, a Chinese fast-food chain operator that owns franchisee rights for the Dairy Queen and Papa John’s Pizza, from existing investor Warburg Pincus.
Accel leads $6m investment in India B2B group buy platform
Accel Partners and return backers Kalaari Capital and Inventus Capital have put $6 million into group buying website Power2SME, in a Series B round for the company.
GCS Capital, Dexia deal in doubt as deadline missed
GCS Capital's proposed EUR380 million ($502 million) purchase of the Dexia's asset management arm has been thrown in to doubt after the Franco-Belgian bank ceased talks on the deal yesterday.
DCM, Infinity invest $2.7m in Japanese accounting software firm
DCM and Infinity Capital Partners have invested $2.7 million in Japanese online accounting software company, Freee, as part of a Series A round of funding.
Taiwan's Chinatrust buys Tokyo Star Bank – report
Chinatrust Commercial Bank, one of Taiwan’s largest commercial lenders, has reportedly agreed to buy Tokyo Star Bank for JPY52 billion ($519 million) from Lone Star and other creditors-turned-shareholders. It would be the first full buyout of a Japanese...
Actis to buy India lighting business from Halonix
Actis is set to buy the loss-making general lighting division of its portfolio company Halonix, a manufacturer of compact fluorescent lamps for general lighting and halogen lamps for automotives.
Arisaig invests $30m for stake in India McDonald's franchisee
Arisaig Partners has bought a 3.47% stake in Mumbai-listed Westlife Development for INR1.8 billion ($30 million). Westlife controls McDonald’s restaurants in west and south India through its direct subsidiary, Hardcastle Restaurants. It is one of two...
Legend Capital joins funding round for heart valve implant maker
Legend Capital has participated in a $62.5 million Series C round of funding for Munich-based JenaValve Technology, a manufacturer of valve systems used to treat heart conditions. The company intends to apply to market products in China.